Coronary Artery Disease I Flashcards
Simple definition of Coronary Artery Disease (CAD)
plaque builds up in an artery
(main BV in heart, uses glucose & fatty acid)
Coronary Artery Disease (CAD) can be…
- A buildup of plaque (ATHEROSCLEROSIS) can narrow coronary arteries, decreasing blood flow to the heart.
- The reduced blood flow may cause chest pain (ANGINA), shortness of breath, or other symptoms.
- A complete blockage can cause a heart attack (MYOCARDIAL INFARCTION; AKA Myocardial Ischemia)
A buildup of plaque (_______) can narrow coronary arteries, decreasing blood flow to the heart.
atherosclerosis
The reduced blood flow may cause chest pain (______), shortness of breath, or other symptoms.
angina
A complete blockage can cause a heart attack (_______).
myocardial infraction (aka myocardial ischemia)
What causes reduced coronary perfusion?
occlusion of the artery
(vasospasm; C.A. constricts or atherosclerosis (stable plaque); permanently decrease CA BF)
Which layer of the artery wall mostly controls the C.A.?
Smooth muscle
- b/c can constrict
Describe the mechanism of atherosclerosis
*check recording
What are the stages of atherosclerosis?
- HEALTHY
- FATTY STREAK
- lipids
- foam cell - FIBROFATTY PLAQUE
- core
- smooth-muscle cell - COMPLICATED PLAQUES
- thrombus
- calcification
What are the key points for the development of atherosclerosis?
- Endothelial cell injury or dysfunction leads to monocyte infiltration and these monocytes are further differentiated into macrophages.
- Oxidized LDLs are trapped in the extracellular matrix of sub-endothelial space.
- Uncontrolled uptake of oxidized lipids by macrophages triggers the formation of foam cells, which augments cytokine release and leads to the development of the fatty streak.
- Smooth muscle cells are proliferated and migrated into intima to induce plaque formation.
- The progression of the lesion induces calcification and changes the mechanical characteristics of the artery wall and predispose to plaque rupture at sites of monocytic infiltration.
- Plaque rupture exposes the flowing blood to tissue factor in the lesion, and this induces thrombosis.
What are the 3 major factors contributing to Atherosclerosis?
- Metabolic dysfunction (hyperlipidemia - high cholesterol)
- Inflammation
- Thrombosis
What is metabolic dysfunction (hyperlipidemia)?
- ↑ Low density lipoprotein (LDL) = bad cholesterol
- ↓ High density lipoprotein (HDL) = good cholesterol
(hyperlipidemia = high cholesterol)
Which lipoprotein or cholesterol is involved in development of atherosclerosis/correlated?
↑ Low density lipoprotein (LDL) = bad cholesterol
Describe Treatment 1: Cholesterol medications
- Aggressively LOWERING LDL cholesterol, the “bad” cholesterol, can slow, stop or even reverse the buildup of fatty deposits in coronary arteries.
- BOOSTING HDL cholesterol, the “good” cholesterol.
- Statins
– Atorvastatin (Lipitor)
– Simvastatin (Zocor)
Why are Statins used as cholesterol medication?
b/c it inhibits enzyme in liver & liver is main place where cholesterol is formed
What are the down sides of using Statins (Atorvastatin (Lipitor), Simvastatin (Zocor))
- Muscle damage if used long-term (measure/monitor)
- May get sclerosis if used for long-time
What is Inflammation?
Atherosclerosis is considered as an inflammatory disease based on the observations of immune activation and inflammatory signalling in human atherosclerotic lesions.
What is the pathology of Atherosclerosis (inflammation)?
- Healthy Artery
- Fatty Streak
- Atherosclerotic plaque
- Plaque rupture or erosion + thrombus formation
(increase Macrophages, T lymphocytes, Dendritic cells with each stage)
Describe Treatment 2: Anti-Inflammatory Therapies
New therapeutic targets:
- innate & adaptive immunity
- pro-inflammatory molecules
yield:
- current therapeutic approach: STATIN
- experimental approaches:
– chemokine antagonists
– TNF-alpha antagonists
– IL1Ra & IL6R antagonists
– regulatory T cell expansion
– CD4+ CD28null T-cell modulation
What is Thrombosis?
- Plaque rupture and superficial erosion typically cause localized, often occlusive thrombus formation.
- The triggering of the coagulation system via factor XIIa, factor VIIa, tissue factor, and ultimately thrombin has a central role in mediating atherothrombosis.
Describe Treatment 3: Anticoagulants
- The prevention of atherothrombotic events is an essential therapeutic goal in the treatment of patients with arteriosclerotic diseases.
- Platelet inhibitors are the primary therapy used to prevent arterial thrombosis.
- Aspirin
- Clopidogrel
What is the primary therapy used to prevent arterial thrombosis?
Platelet inhibitors
What are the recommended Anticoagulants?
- Aspirin
- Clopidogrel